Brazil Continuous Positive Airway Pressure Devices Market (2025 - 2033) Size, Share & Trends Analysis Report By Connectivity (Connected, Non-connected), By End-use (Home Care Settings, Hospitals & Clinics), And Segment Forecasts

Brazil CPAP Devices Market Summary

The Brazil continuous positive airway pressure devices market size was valued at USD 47.27 million in 2024 and is expected to reach USD 81.94 million by 2033, growing at a CAGR of 6.29% from 2025 to 2033. This growth can be attributed to the rising prevalence of sleep apnea, increasing awareness of sleep disorders, advancements in continuous positive airway pressure (CPAP) technology, and the expanding adoption of telemonitoring solutions for therapy adherence. For instance, according to the study published by the National Library of Medicine in February 2023, Obstructive Sleep Apnea (OSA) affects around 50 million inhabitants in Brazil.

The increasing use of advanced technologies that enhance therapy adherence and the rising emphasis on telemonitoring to improve patient outcomes. In addition, the rising focus on early diagnosis further drives the demand for innovative CPAP solutions. According to ResMed's 2024 Sleep Survey, Brazil ranked as the fourth-largest country in terms of sleep apnea diagnosis, with a diagnosis rate of 27%.

Moreover, key players are implementing strategic initiatives, such as new product launches, collaborations, partnerships, and acquisitions & mergers, to increase their market shares. For instance, in June 2024, React Health introduced IntelliPAP features for its V*Home, V+Pro, V+C, and VC+Pro ventilators.

This feature enables automatic adjustment of Positive End-Expiratory Pressure (PEEP) levels during noninvasive ventilation for patients with respiratory insufficiency and OSA. IntelliPAP can adjust PEEP levels by detecting sleep-disordered breathing events, enhancing patient care.

Market Concentration & Characteristics

The degree of innovation in the industry is high. Demand is increasing for sleep apnea treatments that are both easy to use and highly effective. Technology is a key driver as companies focus on improving device features and enhancing user comfort. In addition, investments in research and development are anticipated to drive market growth and support ongoing innovation in the sector. For instance, in March 2024, React Health launched the Luna TravelPAP, a compact and lightweight positive airway pressure device designed for travel. It offers a pressure range of 4 to 20 hPa, a ramp time adjustable from 0 to 60 minutes, and runs at a noise level below 30 dBA, ensuring quiet and convenient therapy on the go.

The M&A activities in the market are low. Companies engage in M&A to strengthen their product portfolios, expand their market reach, and integrate new technologies. For instance, in July 2023, ResMed acquired Somnoware, a company that develops sleep and respiratory diagnostics software.

ANVISA’s modernized medical device framework (RDC 751/2022) aligns Brazil’s classification rules with the EU MDR (four classes I-IV) and determines whether a device is submitted by Notification (Class I/II) or Registration (Class III/IV). The classification outcome drives time-to-market, documentation and fees.

ANVISA has introduced mechanisms (recent guidance/legislation) allowing applicants for higher-risk devices to leverage approvals from trusted foreign regulators in certain situations - creating an accelerated/streamlined path for companies with prior EU/US authorizations.

Product expansion in the Brazil market is medium, with companies introducing new products to meet diverse patient needs. The innovation underscores the company's commitment to advancing solutions for individuals with sleep-related breathing disorders.

Connectivity Insights

The connected CPAP devices segment held the largest revenue share of 68.74% in 2024 and is anticipated to grow at the fastest growth rate over the forecast period. This growth is attributed to the technological advancements, increasing prevalence of sleep apnea, and a growing aging population. Innovations in CPAP devices, such as auto-adjusting machines and mobile health integration, enhance user experience and compliance and are expected to boost the demand for connected CPAP devices. For instance, devices such as ResMed's AirSense 10 and AirSense 11 feature built-in wireless connectivity and companion apps for real-time monitoring.

The non-connected device segment is anticipated to grow at a significant CAGR over the forecast period. Non-connected CPAP devices are considered less expensive since they lack advanced connectivity features. For instance, a budget-conscious user may choose a non-connected CPAP machine that provides effective therapy without the added cost of wireless connectivity or cloud-based services. In addition, these devices are often easier to operate for users who may not be comfortable with technology, especially older adults or those in areas with limited internet access.

End-use Insights

The home care settings segment held the largest revenue share in 2024, and is anticipated to grow at the fastest CAGR during the forecast period due to increasing preference for at-home treatment of sleep apnea and the growing aging population. Patients and healthcare providers favor home-based CPAP therapy for its convenience, cost-effectiveness, and ability to improve adherence. Advancements in portable and user-friendly CPAP devices have increased adoption in residential settings. In addition, the COVID-19 pandemic accelerated the shift toward home care as patients sought safer alternatives to hospital-based treatment for chronic respiratory conditions.

The hospitals & clinics segment is anticipated to grow significantly over the forecast period. These facilities are the first point of contact for patients undergoing sleep studies and receiving CPAP therapy prescriptions. Hospitals provide immediate access to trained professionals and diagnostic tools, ensuring proper device setup and monitoring. In addition, post-operative and critically ill patients with respiratory conditions rely on continuous positive airway pressure (CPAP) devices during recovery.

Key Brazil Continuous Positive Airway Pressure Devices Companies Insights

Key players operating in the Brazil continuous positive airway pressure devices market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling the market growth.

Recent Developments

• In September 2024, ResMed's launch of the AirTouch N30i, a thoroughly fabric sleep apnea mask, exemplifies the industry's commitment to integrating advanced technology with user comfort.

“As a global leader in sleep health and CPAP therapy, millions of people trust ResMed’s devices to help them sleep better and live healthier lives. We are excited to introduce the AirTouch N30i, a mask that redefines comfort with its soft, natural feel and sleek, modern design. It sets a new standard in CPAP masks, helping more people stay committed to their therapy and achieve better sleep while offering a refined aesthetic that is as pleasing to look at as it is to wear.”

- Justin Leong, ResMed chief product officer.

Brazil Continuous Positive Airway Pressure Devices Market Report Scope

Brazil Continuous Positive Airway Pressure Devices Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Brazil continuous positive airway pressure devices market report based on connectivity and end-use.

• Connectivity Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)

  • Connected

    • Bluetooth-Connected CPAP

    • Wi-Fi & Cellular Connected CPAP

    • Hybrid-Connected

  • Non-Connected

• End-use Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)

  • Home Care Settings

  • Hospitals & Clinics

  • Others (Long-Term Care Facilities, etc.)